Professional Guidance
Frequently Asked Questions
ZogniQ™ is a next-generation polarized light therapy system (ZPL) designed to deliver precise, reproducible therapeutic outcomes for ocular, dermatologic, and other medical conditions.
Unlike standard devices, ZogniQ ZPL utilizes polarized light for deeper tissue penetration and enhanced cellular interaction. It also integrates AI-powered imaging and analysis for precise treatment planning and monitoring.
ZogniQ ZPL is designed for a wide range of clinical uses, including ocular conditions (dry eye, meibomian gland dysfunction, blepharitis), dermatology (skin rejuvenation, wound healing, inflammation), and broader therapeutic wellness applications.
Yes. The system uses Patent Pending non-invasive polarized light therapy with built-in safety features like IR, ToF-guided distance monitoring, audible/visual alerts, and precision-controlled energy delivery. Unlike any other system on the market.
The ToF sensor ensures accurate device positioning relative to the patient’s face or treatment area, with real-time proximity alerts and automated energy calculations (J/cm²) for each wavelength—supporting reproducibility and safety.
The recommended frequency of use depends on the condition being treated. For ocular rosacea, Demodex, dry eye, or meibomian gland dysfunction (MGD), begin with an initial procedure followed by three additional sessions every 1–2 weeks. For wrinkle reduction, treatments are typically repeated weekly for 4–6 sessions. In some cases, noticeable improvements may require several months of consistent use.
ZogniQ ZPL incorporates machine learning and AI to analyze ultra-high-resolution (8K) polarized images before and after treatment, helping physicians optimize protocols and track outcomes with accuracy.
The touchscreen provides clear visualization of treatment parameters, multi-parameter display, easy navigation, and room for AI-driven upgrades—making treatments more efficient and precise.
ZogniQ ZPL offers advanced customization options, allowing clinicians to tailor sessions for ocular conditions, dermatology, acute pain, chronic conditions, or general wellness with adjustable wavelengths, intensity, and duration settings.
Yes. ZogniQ ZPL is a software-driven platform with automatic updates. Physicians can also access ZPL treatment protocols developed by leading ophthalmic, optometric and other medical experts.
The platform includes automatic software updates, remote diagnostics, and a robust AI-driven roadmap, with patent-pending features designed to expand functionality over time.
